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Clearance of a primary influenza A virus (IAV) 
infection is known to require killing of virus-
infected  host  cells  by  activated,  antigen-
  specific CD8 T cells in the lungs (Topham et 
al.,  1997).  Until  recently,  antigen-specific 
CD8 T cells were thought to undergo pro-
grammed activation, whereby a single, brief 
interaction with a mature, antigen-bearing DC 
in the LN was sufficient to induce a full pro-
gram of activation, division, and differentia-
tion from naive to mature, cytotoxic CD8 T 
cells  (Kaech  and  Ahmed,  2001;  Wong  and 
Pamer,  2001).  Increasing  evidence  has  sug-
gested, however, that activation of antigen-
specific  CD8  T  cells  is  not  as  simple  as 
previously thought, and multiple factors, in-
cluding cytokine signals such as IL-2 (Wong 
and Pamer, 2004), IFN- (Marrack et al., 1999; 
Price et al., 2000; Kolumam et al., 2005), and 
IL-12 (Curtsinger et al., 2003a,b; Trinchieri, 
2003), and late co-stimulatory signals such as 
CD70 (Dolfi and Katsikis, 2007) and 4-1BBL 
(Bertram et al., 2002; Lin et al., 2009), can 
regulate and fine tune the magnitude and du-
ration of the effector response, as well as the 
nature of the ensuing memory T cell population.
We have recently demonstrated in a model 
of IAV infection that the absence of specific 
pulmonary DC subsets, including plasmacytoid 
DC (pDCs) and CD8+ DCs, from the lungs 
leads to a significant decrease in the number of 
virus-specific CD8 T cells (McGill et al., 2008). 
Reconstitution of the lungs with physiological 
numbers of pDCs or CD8+ DCs is able to re-
store the pulmonary IAV-specific CD8 T cell 
response to near normal levels via a mechanism 
that is dependent on direct DC–T cell interac-
tions, DC-expressed MHC I, and the presence 
of viral antigen. Interestingly, however, this 
rescue is DC subset specific, as reconstitution 
with purified alveolar and airway DCs (aDCs) 
or alveolar macrophages (aMs) was unable to 
rescue the virus-specific CD8 T cell response 
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We have recently demonstrated that peripheral CD8 T cells require two separate activa-
tion hits to accumulate to high numbers in the lungs after influenza virus infection: a 
primary interaction with mature, antigen-bearing dendritic cells (DCs) in the lymph node, 
and a second, previously unrecognized interaction with MHC I–viral antigen–bearing 
pulmonary DCs in the lungs. We demonstrate that in the absence of lung-resident DC 
subsets, virus-specific CD8 T cells undergo significantly increased levels of apoptosis in the 
lungs; however, reconstitution with pulmonary plasmacytoid DCs and CD8+ DCs promotes 
increased T cell survival and accumulation in the lungs. Further, our results show that the 
absence of DCs after influenza virus infection results in significantly reduced levels of  
IL-15 in the lungs and that pulmonary DC–mediated rescue of virus-specific CD8 T cell 
responses in the lungs requires trans-presentation of IL-15 via DC-expressed IL-15R. 
This study demonstrates a key, novel requirement for DC trans-presented IL-15 in promot-
ing effector CD8 T cell survival in the respiratory tract after virus infection, and suggests 
that this trans-presentation could be an important target for the development of unique 
antiviral therapies and more effective vaccine strategies.
© 2010 McGill et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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tenance of an appropriate immune response; however, it   
remains unclear what role IL-15 plays during the effector 
phase of the immune response or in what context IL-15 
  contributes to activated CD8 T cell survival in vivo.
In this study, we demonstrate a previously unrecognized 
role for pulmonary DC–mediated IL-15 trans-presentation in 
regulating virus-specific CD8 T cell responses in the lungs 
after IAV infection. The reduction in T cell numbers observed 
in the lungs of aDC-depleted mice after IAV challenge results 
not from impaired proliferation within the lungs but is caused 
by significantly increased levels of apoptosis of virus-specific 
CD8 T cells compared with nondepleted controls. Further, 
reconstitution with purified pDCs or CD8+ DCs rescues the 
IAV-specific CD8 T cell response by promoting increased 
CD8 T cell survival in the lungs of aDC-depleted mice. 
Additionally, our results show that IAV infection induces up-
regulation of both IL-15 mRNA and protein in the lungs and 
that depletion of aDCs at 48 h post infection (p.i.) results in a 
significant reduction in pulmonary IL-15 expression. Finally, 
this study demonstrates that pulmonary DCs prevent virus-
specific CD8 T cell apoptosis through trans-presentation of 
IL-15, as blockade of IL-15 or IL-15R on the surface of pul-
monary DCs before adoptive transfer, or transfer of IL-15/ 
pulmonary DC subsets ablates the rescue of the virus-specific 
CD8 T cell response in the lungs of aDC-depleted mice.
RESULTS
aDC depletion at 48 h p.i. does not alter proliferation  
of IAV-specific CD8 T cells in the lungs
We have previously demonstrated that aDC depletion at 48 h 
after IAV infection results in increased virus-associated mor-
tality, increased pulmonary viral titers, and significantly re-
duced numbers of virus-specific CD8 T cells in the lungs on 
day 6 p.i. (McGill et al., 2008). To determine the mechanism 
contributing to reduced numbers of CD8 T cells observed in 
the lungs of aDC-depleted mice, we first extended our previous 
studies to determine the extent of this T cell defect in the 
lungs at an earlier time p.i. (i.e., day 4 p.i., when CD8 T cells 
are first beginning to arrive in the lungs; Lawrence and Braciale, 
2004; Lawrence et al., 2005). Given that there are only small 
numbers of virus-specific CD8 T cells in the lungs at early 
time points p.i., we first wanted to confirm that tetramer stain-
ing was specific and sensitive enough to detect the small fre-
quencies of cells in the lungs at day 4 p.i. Therefore, BALB/c 
mice were infected with a sublethal dose of IAV, a sublethal 
dose of influenza type B (which expresses distinct CD8 T cell 
epitopes that do not cross react with those of IAV), or a sub-
lethal dose of respiratory syncytial virus (RSV). On day 4 p.i., 
the mice were sacrificed and their lungs were examined for 
the frequency of CD3+CD8+ CD8 T cells specific for the 
HA204, HA529 (unpublished data), and NP147 epitopes of IAV 
as well as the M282 epitope of RSV. A group of naive mice was 
included as an additional staining control. As seen in Fig. 1 A 
(top), we observe specific staining of tetramer+ CD8 T cells 
after IAV infection, with 1% of CD8 T cells being specific 
to the NP147 epitope, and only 0.1% of staining in samples 
(McGill  et  al.,  2008).  After  IAV  infection  there  is  an 
  abundance  of  IAV  antigen–  and  MHC  I–expressing  cells 
present in the lungs, including infected epithelial cells. Given 
this fact and the inability of all DC subsets to rescue the virus-
specific CD8 T cell response, it suggested that there were ad-
ditional,  undefined  requirements  for  pDC-  and  CD8+ 
DC–mediated rescue of the T cell response in the lungs. Fur-
ther, it remained unclear what mechanism was contributing 
to decreased numbers of IAV-specific CD8 T cells in the lungs 
of  aDC-depleted  mice:  impaired  DC  migration  from  the 
lungs to the LN, impaired CD8 T cell proliferation within 
the lungs, or impaired CD8 T cell survival within the lungs. 
It was also unclear what mechanism pulmonary DC subsets 
were using to rescue this defect.
The cytokine IL-15 has been demonstrated to play a key 
role in promoting lymphoid homeostasis, particularly with re-
spect to CD8 T cells (Budagian et al., 2006; Kim et al., 2008). 
IL-15 was initially thought to signal similar to IL-2, whereby 
IL-15R formed a heterotrimeric complex with IL-2/IL15R 
and common  for high affinity signaling. Although this 
model appears to hold true in certain situations, recent reports 
have demonstrated a unique, alternative signaling mechanism, 
termed trans-presentation. In this model, IL-15R is required 
for the processing and presentation of active IL-15 in trans to 
cells expressing the IL-2/IL15R–common  chain complex 
(Sandau et al., 2004; Schluns et al., 2004; Kobayashi et al., 
2005). At this time, it is unclear which cell types serve as the 
primary trans-presenting cells during an immune response; 
however, several lines of evidence have indicated that DCs 
may play an important role (Burkett et al., 2003, 2004). It is 
known that DCs express protein for both IL-15 and IL-15R, 
and that stimulation by IFN- (Mattei et al., 2001) or IFN- 
(Doherty et al., 1996; Musso et al., 1999), or exposure to 
viral infection leads to further up-regulation of these mole-
cules (Liu et al., 2000; Dubois et al., 2005; Budagian et al., 
2006; Mattei et al., 2009). Interestingly, DCs matured in the 
presence of IL-15 have been demonstrated to promote en-
hanced antigen-specific CD8 T cell proliferation (Jinushi et al., 
2003; Mattei et al., 2009) and a robust Th1 skewing in vivo 
(Pulendran et al., 2004).
IL-15 has been best characterized for its role in maintain-
ing memory CD8 T cell homeostasis, primarily through pro-
moting enhanced basal proliferation (Becker et al., 2002; 
Goldrath et al., 2002; Schluns et al., 2002). More recently, 
however, there is accumulating evidence that IL-15 is also 
important for promoting primary effector CD8 T cell re-
sponses (Akbar et al., 1996; Bulfone-Paus et al., 1997; Vella 
et al., 1998; Schluns et al., 2002; Rausch et al., 2006; Yajima 
et al., 2006). Surface expression of both IL-15R and IL-2/
IL15-R is up-regulated after TCR activation (Vella et al., 
1998), and IL-15 has been proposed to enhance activated 
CD8 T cell survival after challenge with staphylococcal en-
terotoxin A (Vella et al., 1998), Mycobacterium tuberculosis 
(Rausch et al., 2006), and vesicular stomatitis virus infection 
(Sandau et al., 2004). Collectively, these studies suggest a par-
ticularly important role for IL-15 in the generation and main-JEM VOL. 207, March 15, 2010 
Article
523
  labeling technique that allows one to specifically assess cell 
division by T cells in the lungs (McGill and Legge, 2008, 2009). 
In brief, CFSE was administered i.n. to day 4 and 5 infected 
control and aDC-depleted mice, followed 2 h later by i.n. 
BrdU. Using the gating strategy outlined in Fig. 2 A, lung-
resident proliferation was assessed 4 h after BrdU administra-
tion by measuring BrdU incorporation by CFSE+tetramer+ 
CD8 T cells present in the lungs at the time of assay. As seen 
in Fig. 2 B, the frequency of virus-specific CFSE+ CD8 T cells 
that incorporated BrdU in the lungs during the time of assay 
was the same between aDC-depleted mice and nondepleted 
control mice on days 4 and 5 p.i. Further, we observed no 
significant difference in BrdU incorporation by transgenic 
CL-4 CD8 T cells in the lungs of aDC-depleted mice com-
pared with control mice on days 4 or 5 p.i. (Fig. 2, C and D). 
Similarly, no difference in Ki67 staining was observed between 
the polyclonal virus-specific T cell response from aDC-
depleted and nondepleted mice (Fig. S1 C) or between the 
transgenic CL-4 T cell response from aDC-depleted and non-
depleted mice (Fig. S1, A and B). Furthermore, when pDCs 
and CD8+ DCs were adoptively transferred into aDC-
depleted  lungs,  a  reconstitution  that  rescues  pulmonary   
virus-specific CD8 T cell numbers in aDC-depleted mice, 
we still observed no change in the frequency of pulmonary 
antigen-specific CD8 T cells incorporating BrdU (Fig. 2 E) 
or expressing Ki67 (Fig. S1, D and E) on day 5 p.i. Collec-
tively, these results suggest that although total numbers of 
antigen-specific CD8 T cells in the lungs are reduced in aDC-
depleted mice compared with nondepleted controls, the pro-
liferative capacity of IAV-specific CD8 T cells is the same 
between these two groups, and therefore the reduction in 
CD8 T cell numbers in the lungs is not likely a result of differ-
ences in lung-resident T cell expansion.
aDC depletion at 48 h p.i. results in increased virus-specific 
CD8 T cell apoptosis
Given that aDC depletion and pulmonary DC reconstitu-
tion did not alter the levels of lung-resident, IAV-specific 
CD8  T  cell  proliferation  during  IAV  infection,  we  next 
wanted to determine if the decrease in virus-specific CD8 T 
cell numbers in the lungs of aDC-depleted mice was a result 
of increased CD8 T cell apoptosis after their arrival in the 
lungs.  To  this  end,  BALB/c  mice  were  infected  with  or 
without aDC depletion as in Fig. 1 B and assessed for virus-
specific CD8 T cell apoptosis using an FAM caspase 3/7 kit 
on days 4 and 5 p.i. As seen in Fig. 3 (A and B), aDC deple-
tion at 48 h p.i. results in significantly increased frequencies 
of active caspase 3/7+ pulmonary virus-specific CD8 T cells 
on both days 4 and 5 p.i., suggesting that aDC-depleted IAV-
specific CD8 T cells are undergoing increased levels of apop-
tosis in the lungs relative to nondepleted control CD8 T cells. 
Because active caspase 3/7 can also be expressed by acti-
vated  nonapoptotic CD8 T cells (Alam et al., 1999), we 
wanted to confirm that the aDC-depleted CD8 T cells were 
indeed undergoing increased levels of apoptosis and were not 
simply more activated than their control counterparts. We 
from naive, influenza type B– or RSV-infected mice. Further, 
we observe only background levels of staining in IAV-
  infected  samples  using  a  tetramer  containing  the  RSV 
M282 epitope, whereas 0.7% of CD8 T cells are specific to 
this epitope after RSV infection (Fig. 1 A, bottom). Collec-
tively, these results indicate that IAV tetramer staining is both 
sensitive and specific enough to detect very small numbers of 
antigen-specific CD8 T cells found in the lungs early after 
IAV infection. Therefore, we next chose to use this method 
to examine the defect in virus-specific CD8 T cell numbers 
in the lungs of aDC-depleted mice at early time points p.i. 
To this end, BALB/c mice were infected with a sublethal 
dose of IAV with or without aDC depletion at 48 h p.i., and 
the total number of pulmonary CD3+CD8+tetramer+ IAV-
specific CD8 T cells was examined on days 4 and 5 p.i. As 
seen in Fig. 1 (B and C), aDC depletion at 48 h p.i. results in 
reduced numbers of virus-specific CD8 T cells in the lungs 
on day 4 p.i. and significantly reduced numbers of T cells by 
day 5 p.i. Similarly, in experiments that used the adoptive 
transfer of transgenic clone-4 (CL-4) CD8 T cells, which are 
specific for the HA protein of IAV (McGill et al., 2008), we 
observed a reduction in the numbers of CL-4 CD8 T cells in 
the lungs of aDC-depleted host mice relative to nondepleted 
controls on days 4 and 5 p.i. (Fig. 1, D and E).
The decrease in virus-specific CD8 T cell numbers ob-
served in the lungs of aDC-depleted mice could be attrib-
uted to two potential possibilities: (1) decreased proliferation   
of antigen-specific CD8 T cells after arriving in the lungs   
or (2) decreased survival/increased apoptosis of antigen-
  specific CD8 T cells after arriving in the lungs. Although a 
potential third mechanism exists whereby virus-specific CD8 
T cells are impaired in their ability to home to the lungs in 
the absence of pulmonary DC subsets, our previous work 
(McGill et al., 2008) suggests that this is not likely to be the 
primary mechanism contributing to the decreased pulmo-
nary CD8 T cell numbers. First, we have observed similar 
numbers of IAV-specific CD8 T cells in the blood, spleens, 
and  nondraining  LN  of  control  and  aDC-depleted  mice. 
Further, the adoptive transfer of 2M/ or influenza B 
  antigen–bearing pulmonary DC subsets was not sufficient to 
rescue the virus-specific T cell response, whereas influenza B 
antigen–bearing DCs pulsed with IAV antigens were able to 
rescue the response (McGill et al., 2008). These findings sug-
gest the requirement for a direct interaction between pulmo-
nary DCs and CD8 T cells already present in the lungs rather 
than a defect in DC-mediated recruitment of CD8 T cells into 
the lungs from the blood or secondary lymphoid organs.
Given the cognate MHC I–viral peptide–dependent nature 
of pulmonary DC–T cell interactions in the lungs of aDC-
depleted mice (McGill et al., 2008), we expected that increased 
T cell proliferation was the primary mechanism contributing 
to the rescue of the CD8 T cell response after pulmonary DC 
reconstitution. Therefore, we first assessed proliferation by 
virus-specific CD8 T cells in the lungs of aDC-depleted mice 
compared with nondepleted controls. Our laboratory has pre-
viously developed a novel intranasal (i.n.) CFSE/BrdU dual-524 DC IL-15 mediates peripheral T cell survival | McGill et al.
lungs of aDC-depleted mice relative to nondepleted con-
trol lungs. In further support of our results examining apop-
tosis by the polyclonal IAV-specific T cells, we observed a 
similar increase in apoptotic, transgenic CL-4 CD8 T cells 
in the lungs of aDC-depleted mice compared with control 
mice (Fig. S2). Collectively, these results demonstrate that 
aDC depletion at 48 h p.i. results in increased apoptosis of 
  virus-specific CD8 T cells in the lungs on days 4 and 5 p.i. 
and suggest that virus-specific CD8 T cells require interac-
tions with pulmonary DCs in the lungs to survive and   
accumulate to sufficient numbers to control viral infection.
therefore confirmed our results using the same experimental 
approach as in Fig. 3 (A [top] and B), but instead assessed 
apoptosis using an FAM active caspase 8 kit (Fig. 3, A [mid-
dle] and C), as well as annexin V/7-AAD staining (Fig. 3 
A, bottom) as a measurement of early (Fig. 3 D) and late 
(Fig. 3 E) stage apoptosis. Similar to the results examining ac-
tive caspase 3/7 (Fig. 3 B), we observed an increased fre-
quency of caspase 8+ virus-specific CD8 T cells on days 4 and 
5 p.i. in aDC-depleted mice. Further, using annexin V/7-
AAD staining as a measure of apoptosis, we again observed 
increased levels of virus-specific CD8 T cell death in the 
Figure 1.  aDC depletion at 48 h p.i. results in reduced numbers of IAV-specific CD8 T cells in the lungs on days 4 and 5 p.i. (A) Groups of 
mice were infected with either a sublethal dose of IAV, influenza type B, or the A2 strain of RSV. One group of mice remained uninfected. On day 4 p.i., the 
mice were sacrificed and their lungs were analyzed by flow cytometry for the frequencies of influenza NP147-specific and RSV M282-specific tetramer+ CD8 
T cells. Representative FACS plots are gated on CD3+CD8+ T cells. Data are representative of one experiment (n = 2–3 mice/group). (B and C) Groups of 
BALB/c mice were infected with a sublethal dose of IAV. Half of the mice were aDC depleted at 48 h p.i. (aDC depleted), whereas the other half remained 
nondepleted (control). On days 4 and 5 p.i., the frequency (B) and number (C) of antigen-specific tetramer+ CD8 T cells in the lungs were enumerated. Rep-
resentative FACS plots are gated on CD3+CD8+ T cells. Numbers of tetramer+ CD8 T cells in the lungs were determined by subtracting background staining 
using the media control (B, top). Data are pooled from two separate experiments and represent means ± SEM (n = 5–9 mice/group). (D and E) Influenza-
specific, CD90.2+ CL-4 T cells were adoptively transferred to groups of CD90.1+ BALB/c mice as described in Materials and methods. 24 h later, mice were 
infected with a sublethal dose of IAV. Half of the mice were aDC depleted at 48 h p.i. (aDC depleted), whereas the other half remained nondepleted (con-
trol). On days 4 and 5 p.i., the frequency (D) and number (E) of CD90.2+, adoptively transferred CL-4 T cells were determined by flow cytometry. Represen-
tative FACS plots are gated on CD3+CD8+ T cells. Data are representative of three separate experiments and represent means ± SEM (n = 3–4 mice/group).JEM VOL. 207, March 15, 2010 
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Figure 2.  aDC depletion at 48 h p.i. does not alter IAV-specific CD8 T cell proliferation in the lungs. (A and B) Groups of BALB/c mice were in-
fected with a sublethal dose of IAV. Half of the mice were subsequently aDC depleted at 48 h p.i. (aDC depleted), whereas the other half remained nonde-
pleted (control). On days 4 and 5 p.i., mice were administered CFSE i.n, followed 2 h later by BrdU i.n. 4 h after BrdU administration, the proliferation, as 
measured by BrdU incorporation, of lung-resident CFSE+tetramer+ CD8 T cells was assessed by flow cytometry using the gating strategy outlined in A. Data 
in A and B are representative of two to three separate experiments (n = 5–8 mice/group). (C and D) Influenza-specific, CD90.2+ CL-4 T cells were adoptively 
transferred to groups of CD90.1+ BALB/c mice as in Fig. 1 (D and E). 24 h later, mice were infected with a sublethal dose of IAV with or without aDC deple-
tion. On days 4 and 5 p.i., mice were treated with i.n. CFSE and BrdU. 4 h after BrdU administration, mice were sacrificed and their lungs were analyzed by 
flow cytometry for the frequency of BrdU+ cells among CFSE+CD8+CD90.2+ T cells using the representative gating strategy shown in C. Data in C and D are 
representative of one experiment (n = 3–5 mice/group). (E) Mice were infected and aDC depleted as in A and B; however, groups of aDC-depleted mice were 
subsequently reconstituted with purified pulmonary pDCs (light gray bars) or CD8+ DCs (dark gray bars) on day 3 p.i. (i.e., 24 h after depletion). On day 5 p.i., 
virus-specific CD8 T cell proliferation was determined as in A and B. Data in E are representative of two to three separate experiments (n = 5–8 mice/group). 
Means ± SEM are shown. No statistical difference was observed between the analyzed groups. SSC, side scatter.526 DC IL-15 mediates peripheral T cell survival | McGill et al.
and day 6 p.i. aDC-depleted lung homogenates showed that 
IAV infection induces an approximately fivefold increase 
in  pulmonary  IL-15  mRNA  expression  relative  to  naive 
Pulmonary DC reconstitution promotes increased  
lung-resident, virus-specific CD8 T cell survival  
after aDC depletion
Given our results demonstrating that aDC depletion induced 
increased apoptosis of virus-specific CD8 T cells in the lungs 
after IAV infection, we next determined if pulmonary DC 
reconstitution 24 h after aDC depletion would be sufficient 
to promote increased survival and accumulation of CD8 T cells 
in the lungs. Therefore, groups of mice were influenza virus 
infected with or without aDC depletion. 24 h after DC 
depletion, mice were reconstituted i.n. with purified pulmo-
nary pDCs or CD8+ DCs as in Fig. 2 E. On day 5 p.i., the 
lungs were assessed for frequencies (Fig. 4 A) and total num-
bers of tetramer+ CD8 T cells (Fig. 4 C), as well as the fre-
quency of tetramer+ CD8 T cell apoptosis as measured by 
active caspase 3/7 expression (Fig. 4, B and D). Similar to our 
previous results, we observed a significant rescue in the fre-
quency and number of pulmonary tetramer+ CD8 T cells after 
reconstitution with purified pDCs or CD8+ DCs relative to 
nonreconstituted aDC-depleted control mice (Fig. 4, A and 
C). Consistent with the rescue of pulmonary IAV-specific 
CD8 T cell numbers, we also observed a significant reduc-
tion in the frequency of apoptotic CD8 T cells in the lungs 
on day 5 p.i. after reconstitution with either pDCs or CD8+ 
DCs (Fig. 4, B and D), with levels of CD8 T cell apoptosis 
being similar to those of nondepleted control CD8 T cells. A 
similar trend was also seen when examining the frequency of 
active caspase 8+ T cells (unpublished data). Collectively, these 
results suggest that virus-specific CD8 T cell interactions with 
pulmonary pDCs and CD8+ DCs provide key survival sig-
nals, allowing T cells to accumulate to high numbers in the 
lungs after IAV infection.
aDC depletion at 48 h p.i. results in decreased pulmonary 
IL-15 expression
Given our results suggesting that donor pulmonary DCs 
were positively regulating virus-specific CD8 T cell responses 
in the lungs of aDC-depleted mice through the promotion 
of increased CD8 T cell survival, and our previous studies 
demonstrating that the rescue of IAV-specific, aDC-depleted 
CD8 T cell responses requires direct DC–T cell interactions, 
MHC I, viral antigens, and specific DC subsets, we next 
sought to identify what additional survival signals the pDCs 
and CD8+ DCs were providing. Therefore, we performed 
focused  superarray  analysis  on  whole  lung  homogenates   
from day 6 infected control and aDC-depleted lungs as well 
as on purified DC subsets. Interestingly, we observed de-
creased expression of IL-15 mRNA in aDC-depleted lungs. 
Further, IL-15 mRNA expression was more robustly expressed 
by pDCs and CD8+ DCs (unpublished data), the two DC 
subsets significantly reduced in the lungs of aDC-depleted 
mice and known to restore pulmonary CD8 T cell responses 
upon reconstitution (McGill et al., 2008) relative to other pul-
monary APC populations. Similar to our initial array results, 
quantitative  real-time  RT-PCR  (qRT-PCR)  analysis  for 
IL-15 expression by naive, day 6 p.i. control IAV-infected 
Figure 3.  aDC depletion at 48 h p.i. results in increased apoptosis of 
IAV-specific CD8 T cells in the lungs. Groups of BALB/c mice were in-
fected with a sublethal dose of IAV with or without aDC depletion as in Fig. 
1. On days 4 and 5 p.i., mice were sacrificed and their lungs were analyzed 
by flow cytometry for apoptosis of tetramer+ CD8 T cells as measured by the 
frequency of active caspase 3/7+ (A, top; and B), active caspase 8+ (A, mid-
dle; and C), and annexin V+7-AADneg and annexin V+7-AAD+tetramer+ CD8 
 T cells (A, bottom; and D and E). Representative FACS plots from day 4 p.i. are 
gated on CD3+CD8+tetramer+ CD8 T cells. Data are representative of three to 
four separate experiments (n = 3–6 mice/group). Means ± SEM are shown.JEM VOL. 207, March 15, 2010 
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control lungs (Fig. 5 A). Strikingly, however, aDC depletion 
at 48 h p.i. resulted in a significant reduction in IL-15 mRNA 
expression, with expression levels reduced to approximately 
twofold gene induction over naive (Fig. 5 A). This change in 
mRNA expression was reflected at the protein level, as we 
observed a significant reduction in IL-15 protein expression 
by aDC-depleted lungs relative to nondepleted controls   
(Fig. 5 B). Collectively, these results demonstrated that aDC 
depletion at 48 h p.i. results in a significant reduction in the 
expression of IL-15 message and protein in the lungs during 
IAV infection.
Pulmonary pDCs and CD8+ DCs express IL-15 mRNA  
and surface IL-15R
Given the previously described role for IL-15 in promoting 
effector CD8 T cell responses (Akbar et al., 1996; Bulfone-
Paus et al., 1997; Vella et al., 1998; Schluns et al., 2002; 
Rausch et al., 2006; Yajima et al., 2006), its potential ability 
to promote CD8 T cell survival (Akbar et al., 1996; Bulfone-
Paus et al., 1997; Vella et al., 1998; Rausch et al., 2006; 
Yajima et al., 2006), and the ability of the purified pulmonary 
DC subsets that express robust levels of IL-15 mRNA to   
rescue IAV-specific CD8 T cells from apoptosis in the lungs   
after aDC depletion, we next determined if these subsets were 
indeed capable of making and presenting IL-15 to IAV-
  specific CD8 T cells in the lungs. We first confirmed the re-
sults of our arrays by performing qRT-PCR for IL-15 mRNA 
expression on DC subsets purified from the lungs of day 6 p.i. 
donors. As seen in Fig. 6 A, both pDCs and CD8+ DCs ex-
press high levels of IL-15 mRNA. In contrast, aMs, another 
prevalent APC population in the lungs during IAV infection 
that is incapable of rescuing IAV-specific CD8 T cell re-
sponses, expressed lower levels of IL-15 mRNA (60% of 
pDCs/CD8+ DCs).
Because the ability to trans-present IL-15 to other cells 
requires surface expression of IL-15R, we next verified that 
both pDCs and CD8+ DCs expressed detectable levels of the 
receptor. As seen in Fig. 6 B, pDCs, CD8+ DCs, and aMs 
all expressed IL-15R on their surface, suggesting they could 
potentially trans-present IL-15 to other cell types.
IL-15 presented on the surface of pulmonary DC subsets 
promotes increased accumulation of IAV-specific CD8  
T cells in the lungs of aDC-depleted mice
Having demonstrated that pDCs and CD8+ DCs have the 
potential to trans-present IL-15 to other cell types, that 
aDC-depleted lungs express reduced levels of IL-15 pro-
tein, and that reconstitution with pDCs or CD8+ DCs is 
able to rescue CD8 T cell responses in the lungs of aDC-
Figure 4.  Pulmonary DC reconstitution of aDC-depleted mice results 
in decreased apoptosis of IAV-specific CD8 T cells in the lungs. Groups 
of BALB/c mice were infected with a sublethal dose of IAV with or without 
aDC depletion as in Fig. 1. On day 3 p.i., groups of aDC-depleted mice were 
reconstituted i.n. with 2.5 × 104 pulmonary pDCs (light gray bars) or CD8+ 
DCs (dark gray bars) purified from the lungs of IAV-infected donors. On day 
5 p.i., the frequency (A) and number (C) of tetramer+ CD8 T cells, and the 
frequency of apoptotic, tetramer+ CD8 T cells (B and D) per lung were mea-
sured. Data in A are representative FACS plots gated on CD3+CD8+ T cells. 
Numbers of tetramer+ CD8 T cells in the lungs were determined by subtract-
ing background staining using the media control (A, top). Data in B are rep-
resentative FACS plots gated on CD3+CD8+tetramer+ T cells. Data in C and D 
are pooled from two separate experiments (n = 6 mice/group). Means ± 
SEM are shown. *, P ≤ 0.05 relative to undepleted control group.
Figure 5.  aDC depletion at 48 h p.i. results in decreased pulmo-
nary IL-15 mRNA and protein expression. Groups of BALB/c mice were 
infected with a sublethal dose of IAV with or without aDC depletion as in 
Fig. 1. (A) On day 6 p.i., lungs were removed and analyzed using qRT-PCR 
analysis for IL-15 expression. Results were normalized to GAPDH expres-
sion, and then to expression of IL-15 mRNA by naive lungs to calculate 
the Ct. Data are pooled from two separate experiments and represent 
means ± SEM (n = 3–6 mice/group). (B) On day 6 p.i., lung homogenates 
from groups of naive, control, and aDC-depleted mice were analyzed for 
IL-15 protein expression by ELISA as described in Materials and methods. 
The dashed line represents the limit of detection of the assay. Data are 
representative of four separate experiments and represent means ± SEM 
(n = 5 mice/group). ND, not detected.528 DC IL-15 mediates peripheral T cell survival | McGill et al.
and  hence  a  shortened  half-life,  we  did  not  observe   
significant  differences  in  DC  recovery  from  the  lungs 
when comparing uncoated, or anti–IL-15 or anti–IL-15R 
antibody–coated pDCs or CD8+ DCs (unpublished data). 
This suggests that differences observed in the ability of the 
DCs to promote IAV-specific CD8 T cell rescue in this   
experiment were not a result of enhanced clearance of the 
DCs in vivo because of Fc-mediated mechanisms.
However, given this potential limitation of our in vivo 
antibody blocking approach, we confirmed our results using 
the adoptive transfer of IL-15/ pulmonary DC subsets. To 
this end, we infected wild-type C57BL/6 host mice with a 
sublethal dose of IAV strain A/PR/8/34 (H1N1). Mice were 
then aDC depleted at 48 h p.i., followed by i.n. reconstitu-
tion on day 3 p.i. with pulmonary pDC or CD8+ DC sub-
sets purified from the lungs of day 6 A/PR/8/34-infected 
wild-type or IL-15/ C57BL/6 donor mice. On day 7 p.i., 
the numbers of IAV PA224- and NP366-specific CD8 T cells 
(Fig. 7 C) in the lungs were measured by tetramer staining 
and intracellular cytokine staining (ICS) for IFN-. In agree-
ment with our results using the IL-15 or IL-15R blocking 
antibodies (Fig. 7, A and B; and Fig. S3), reconstitution with 
IL-15/ pulmonary DCs ablated donor DC rescue of the 
IAV-specific CD8 T cell response (Fig. 7 C). Importantly, 
given that these experiments were performed in IL-15+/+ 
mice, this trans-presentation must be mediated specifically by 
pulmonary pDCs or CD8+ DCs, as the presence of other 
IL-15–expressing cells in the lungs could not compensate for 
the absence of the IL-15+/+ pulmonary DC subsets.
depleted mice, we next directly determined the role of pul-
monary DC–expressed IL-15 and IL-15R in our aDC 
depletion/reconstitution system. To this end, BALB/c mice 
were infected with a sublethal dose of IAV with or without 
aDC depletion at 48 h p.i. On day 3 p.i., pulmonary pDCs 
or CD8+ DCs were purified and then coated in vitro with 
anti–mouse IL-15R (Fig. 7 A) or IL-15 (Fig. 7 B) block-
ing antibodies before adoptive transfer into aDC-depleted 
host mice. As seen in Fig. 7 A, although adoptive transfer of 
control  pDCs  or  CD8+  DCs  into  aDC-depleted  lungs 
promotes increased IAV-specific CD8 T cell responses as 
measured by tetramer or intracellular staining for IFN-, 
adoptive transfer of pDCs or CD8+ DCs coated with 
anti–IL-15R  blocking  antibodies  ablates  the  rescue  of 
pulmonary IAV-specific CD8 T cell responses in the lungs 
of DC-reconstituted mice. Similarly, using our CL-4 adop-
tive transfer system, we observed that reconstitution with 
pDCs or CD8+ DCs rescued the numbers of virus-specific 
CL-4 T cells in the lungs, but blockade of IL-15R on   
the DCs before their adoptive transfer prevented the DC-
mediated rescue of CL-4 CD8 T cell numbers in the lungs 
of aDC-depleted mice (Fig. S3). Like the results observed 
in Fig. 7 A, if pulmonary DC subsets are instead coated 
with anti–IL-15 blocking antibodies before their transfer 
into aDC-depleted lungs, there is again an ablation of the 
rescue  effect  mediated  by  control  pulmonary  pDCs  or 
CD8+ DCs (Fig. 7 B). Although coating of DCs with IL-
15 or IL-15R blocking antibodies before their adoptive 
transfer in vivo could potentially result in their clearance 
Figure 6.  Pulmonary pDCs and CD8+ DCs express IL-15 and IL-15R. (A) Groups of BALB/c mice were infected with a sublethal dose of IAV. On 
day 6 p.i., lungs were pooled and pDCs, CD8+ DCs, and aMs were FACS purified and analyzed by qRT-PCR analysis for IL-15 expression. Results were 
normalized to GAPDH expression. Data are pooled from three separate experiments and represent means ± SEM. (B) Groups of BALB/c mice were infected 
with a sublethal dose of IAV. On day 6 p.i., pDCs, CD8+ DCs, and aMs in the lungs were analyzed for surface expression of IL-15R (continuous line) 
versus isotype control (shaded) by flow cytometry. Data are representative of three separate experiments.JEM VOL. 207, March 15, 2010 
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depleted mice. Therefore, we infected BALB/c mice with 
IAV, depleted aDCs at 48 h p.i., and reconstituted them 
with purified control pulmonary DC subsets, anti–IL-15 
blocking antibody–coated pulmonary DC subsets, or anti– 
IL-15R blocking antibody–coated DC subsets as in Fig. 7 
(A and B). On day 5 p.i., the frequency of expression of ac-
tive caspase 3/7 by tetramer+ CD8 T cells in the lungs was 
measured as in Figs. 3 and 4. Similar to our previous results, 
we observed significantly increased levels of apoptosis as 
measured by an increased frequency of active caspase 3/7+ cells 
among the lung tetramer+ CD8 T cell population of aDC-
depleted mice compared with nondepleted controls (Fig. S4). 
IL-15 presented on the surface of pulmonary DC subsets 
promotes increased survival of IAV-specific CD8 T cells  
in the lungs of aDC-depleted mice
Given our observation that blocking IL-15 or IL-15R on 
the surface of pDCs and CD8+ DCs before their adoptive 
transfer ablated the rescue of influenza-specific CD8 T cell 
responses in the lungs of aDC-depleted mice, and the docu-
mented role of IL-15 in promoting effector CD8 T cell sur-
vival in vitro, we next hypothesized that DC IL-15–induced 
signaling may be providing survival signals to activated CD8 
T  cells  in  vivo,  therein  allowing  increased  accumulation   
of IAV-specific CD8 T cell responses in the lungs of aDC-
Figure 7.  Pulmonary pDC– and CD8+ DC–mediated rescue of IAV-specific CD8 T cell responses from aDC-depleted mice requires IL-15 
trans-presentation. Groups of BALB/c mice were infected with a sublethal dose of IAV with or without aDC depletion as in Fig. 1. On day 3 p.i., groups of 
aDC-depleted mice were reconstituted i.n. with 2.5 × 104 purified pulmonary pDCs (light gray bars) or CD8+ DCs (dark gray bars) that were left untreated 
or blocked in vitro with (A) anti–IL-15R antibody or (B) anti–IL-15 antibody before adoptive transfer. On day 6 p.i., the number of pulmonary antigen-
specific CD8 T cells was enumerated by tetramer staining (left) or ICS for IFN- (right). Data are pooled from three separate experiments and represent 
means ± SEM (n = 9–12 mice/group). (C) Groups of C57BL/6 mice were infected with a sublethal dose of IAV and aDCs depleted at 48 h p.i. (black bars), 
whereas controls remained undepleted (white bars). On day 3 p.i., groups of aDC-depleted mice were then reconstituted i.n. with 2.5 × 104 purified pul-
monary pDCs (light gray bars) or CD8+ DCs (dark gray bars) that were purified from IAV-infected C57BL/6 IL-15/ (KO) or wild-type IL-15+/+ donors. On 
day 7 p.i., the number of pulmonary IAV-specific CD8 T cells was enumerated by tetramer staining (left) or ICS for IFN- (right). Data are pooled from two 
separate experiments and represent means ± SEM (n = 6–7 mice/group). *, P ≤ 0.05 relative to undepleted control group.530 DC IL-15 mediates peripheral T cell survival | McGill et al.
in  significantly  reduced  numbers  of  pulmonary  influenza-
  specific CD8 T cells compared with mice receiving control 
Fc fragments. Additionally, we observed a significantly in-
creased frequency of IAV-specific CD8 T cell apoptosis in IL-
15R/Fc chimera–treated lungs relative to control-treated 
lungs. In agreement with our results blocking IL-15 trans-
presentation using the IL-15R/Fc chimera, IAV infec-
tion of IL-15/ mice also resulted in significantly reduced 
frequencies and numbers of IAV-specific CD8 T cells in the 
lungs (Fig. S5), further confirming an important role for IL-
15 trans-presentation in regulating the magnitude of the pul-
monary  effector  CD8  T  cell  response.  Importantly,  these 
results demonstrate a novel role for pulmonary IL-15 signal-
ing in regulating the magnitude of antigen-specific CD8 T 
cell responses in the lungs after IAV infection, and lend sup-
port to our results suggesting that pulmonary DCs are pro-
viding these IL-15–mediated signals to CD8 T cells during 
infection via direct cell-to-cell contact and trans-presentation 
by IL-15R. Collectively, these results suggest that the DC-
mediated rescue of IAV-specific CD8 T cells from death in 
the lungs of aDC-depleted mice requires IL-15 trans-presen-
tation by pulmonary DC subsets. The results further suggest 
a model whereby IAV-specific CD8 T cells require a two-hit 
model of priming to accumulate sufficient numbers to con-
trol IAV infection, with the first interaction being that of LN 
Reconstitution  with  IL-15  or  IL-15R  antibody–coated 
pulmonary pDCs or CD8+ DCs did not result in a signifi-
cant reduction in the frequency of apoptotic, IAV-specific 
CD8 T cells in the lungs of aDC-depleted mice.
Our results thus far suggest a model whereby pulmonary 
DCs trans-present IL-15 to effector CD8 T cells to promote 
T cell survival and accumulation therein. We have examined 
the role of IL-15 by using an aDC depletion and pulmonary 
DC reconstitution approach, whereby we eliminate a variety 
of pulmonary DC–mediated signals and examine the role of 
IL-15 in this context. We next sought to determine the role 
of IL-15 alone, in an otherwise pulmonary DC–sufficient en-
vironment, in promoting effector CD8 T cell survival after 
IAV infection. To this end, we chose to block IL-15 presen-
tation in the lungs through the use of recombinant mouse 
IL-15R/Fc fusion protein. Therefore, we infected BALB/c 
mice with a sublethal dose of IAV, treated groups of mice i.n. 
on days 3, 4, and 5 p.i. with mouse IL-15R/Fc fusion pro-
tein or control human Fc fragments, and analyzed the lungs 
on day 6 p.i. for the frequency (Fig. 8 A) and total number 
(Fig. 8 C) of tetramer+ IAV-specific CD8 T cells as well as 
the frequency of apoptotic IAV-specific CD8 T cells (Fig. 8, 
B  and  D).  In  agreement  with  our  results  using  the  aDC   
depletion/reconstitution system (Fig. 7), the administration 
of the blocking mouse IL-15R/Fc fusion protein resulted 
Figure 8.  IL-15R–Fc administration results in reduced IAV-specific CD8 T cell responses and increased CD8 T cell apoptosis in the lungs 
after IAV infection. Groups of BALB/c mice were infected with a sublethal dose of IAV. On days 3, 4, and 5 p.i., mice were i.n. administered IL-15R–
Fc (black bars) or control human Fc fragments (white bars). On day 6 p.i., the lungs were analyzed for (A) the frequency and (C) number of tetramer+ 
CD8 T cells or (B and D) for apoptosis of tetramer+ CD8 T cells. Representative FACS plots are gated on (A) CD3+CD8+ T cells or (B) CD3+CD8+tetramer+ 
T cells. Numbers of tetramer+ CD8 T cells in the lungs were determined by subtracting background staining using the media control (A, left). Data are 
representative of two separate experiments and represent means ± SEM (n = 3–5 mice/group).JEM VOL. 207, March 15, 2010 
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Although this study suggests a novel role for pulmonary 
DC IL-15 trans-presentation to CD8 T cells in the lungs after 
IAV infection, previous reports have shown that IL-15 can 
regulate CD8 T cell responses both in vivo and in vitro. For 
example, IL-15/ mice undergoing a primary infection by 
vesicular stomatitis virus have an 50% reduction in the CD8 
T cell response compared with wild-type controls (Schluns et 
al., 2002). Similarly, IL-15/ mice infected with M. tuberculo-
sis exhibit significantly reduced numbers of CD8 T cells in the 
lungs and mediastinal LN (Rausch et al., 2006). Importantly, 
although these cells were shown to undergo similar rates of 
proliferation compared with wild-type CD8 T cells as mea-
sured by BrdU incorporation, annexin V staining revealed a 
significant increase in the level of apoptosis in IL-15/ CD8 
T cells relative to wild-type controls (Rausch et al., 2006). 
These results are in accordance with several other reports sug-
gesting that IL-15 is crucial for promoting the survival of acti-
vated mouse CD8 T cells both in vitro and in vivo. These 
include experiments demonstrating the importance of IL-15 
after cytokine starvation induced by IL-2 withdrawal (Akbar 
et al., 1996), after in vitro activation with the superantigen 
staphylococcal enterotoxin A (Vella et al., 1998), and after sys-
temic administration of the anti-Fas monoclonal antibody Jo2 
(Bulfone-Paus et al., 1997). Interestingly, however, IL-15/ 
mice infected with lymphocytic choriomeningitis virus mount 
a robust primary CTL response (Becker et al., 2002). Collec-
tively, these results suggest that the requirement for IL-15 by 
effector CD8 T cells may differ depending on the infectious 
agent and type of ensuing immune response.
At this time, the molecular mechanisms regulating the IL-
15–mediated rescue of virus-specific CD8 T cells by pulmo-
nary DC subsets in the lungs remain unclear. Previous reports 
examining the molecular basis for IL-15–mediated protection 
from apoptosis after IL-2 withdrawal in vitro suggested that 
although IL-15 signaling did not inhibit the expression of the 
proapoptotic molecules Bax or Bcl-xS (Akbar et al., 1996), it 
promoted strong induction of the important antiapoptotic 
molecules Bcl-2 and Bcl-xL (Akbar et al., 1996; Yajima et al., 
2006). Bcl-2 has been demonstrated to play a critical role in 
activated CD8 T cell survival, and the balance between pro-
apoptotic Bim and Bcl-2 is key in regulating activated CD8 
T cell survival in a variety of model systems (Marrack and 
Kappler, 2004). In accordance with these findings, our pre-
liminary results suggest that pulmonary aDC-depleted virus-
specific CD8 T cells express lower levels of Bcl-2 but increased 
levels of Bim compared with CD8 T cells from non-aDC–
depleted mice (unpublished data). Collectively, these results 
indicate that the increased apoptosis of aDC-depleted T cells 
may result from an imbalance in the Bim/Bcl-2 ratio. Fur-
ther, IL-15–mediated signaling may be one of the important 
factors promoting Bcl-2 up-regulation after T cell activation, 
thereby determining subsequent survival or apoptosis of CD8 
T cells. In the future, it will be important to perform a more 
detailed molecular analysis to determine the role of IL-15 in 
promoting virus-specific CD8 T cell survival in the lungs   
after IAV infection.
priming to initiate programmed activation, differentiation, and 
proliferation, and with the second interaction being in the 
lungs with pDCs or CD8+ DCs bearing MHC I and IAV-
derived antigen as well as IL-15R trans-presenting IL-15.
DISCUSSION
Our previous studies have demonstrated that the ability to res-
cue IAV-specific CD8 T cell responses in the lungs of aDC-
depleted mice was specific to pulmonary pDCs, CD8+ DCs, 
and interstitial DCs, as adoptive transfer of aDCs or aMs or 
the presence of MHC I–viral antigen–bearing epithelial cells in 
the lungs of aDC-depleted mice is not sufficient to rescue the 
T cell response therein (McGill et al., 2008). Although it re-
mains unclear why aDCs and aMs are not sufficient to rescue 
IAV-specific CD8 T cell responses in the lungs, our prelimi-
nary results showed that aDCs and aMs express reduced levels 
of IL-15 (Fig. 6 and not depicted) when compared with pDCs 
and CD8+ DCs, which express high levels of IL-15 mRNA. 
Further, our preliminary experiments suggest that after addi-
tion of exogenous IL-15, adoptively transferred aDCs may be 
able to rescue IAV-specific CD8 T cell responses in aDC-
  depleted mice. These results suggest that the reduced levels of 
IL-15 expression by aMs and aDCs may be a key factor in 
preventing aMs and aDCs from rescuing the T cell response 
in DC-depleted mice. Further, given the abundance of late co-
stimulatory molecules and cytokine signals previously demon-
strated to regulate the magnitude of IAV-specific CD8 T cell 
responses, including 4-1BB (Bertram et al., 2002; Lin et al., 
2009), OX40L (Humphreys et al., 2003; Bansal-Pakala et al., 
2004), CD70 (Halstead et al., 2002; Dolfi and Katsikis, 2007), 
and IFN- (Marrack et al., 1999; Price et al., 2000; Kolumam 
et al., 2005), it is possible that in addition to IL-15, MHC I and 
viral antigen, pulmonary DCs may provide additional signals 
that are necessary for the rescue of virus-specific CD8 T cell 
response in the lungs of aDC-depleted mice.
In addition to the important role that pDCs and CD8+ 
DCs  play  in  regulating  IAV-specific  T  cell  immunity,   
Aldridge et al. (2009) have recently demonstrated an impor-
tant role for TNF/iNOS-producing DCs (tipDCs) in interact-
ing  with  antigen-specific  CD8  T  cells  after  IAV  infection 
(Aldridge et al., 2009). Elimination of tipDC recruitment to 
the lungs using a CCR2/ mouse resulted in a significant re-
duction in the number of virus-specific CD8 T cells in the 
lungs after infection. Reconstitution of the lungs with purified 
tipDCs restored the virus-specific CD8 T cell response in the 
lungs via a mechanism that required viral antigen. These re-
sults expand on our previously published findings and suggest 
that in addition to interstitial DCs, pDCs, and CD8+ DCs, 
tipDCs are also capable of interacting with pulmonary CD8 T 
cells to promote increased effector responses in the lungs. It 
remains unclear, however, what mechanism is responsible for 
increased CD8 T cell responses after tipDC reconstitution, 
and it will be important to determine if tipDCs are likewise 
promoting  increased  CD8  T  cell  survival  via  IL-15  trans-
  presentation, or if tipDCs use a unique mechanism to promote 
CD8 T cell accumulation in the lungs (Aldridge et al., 2009).532 DC IL-15 mediates peripheral T cell survival | McGill et al.
and PA224 (H2D(b)/SSLENFRAYV) and NP366 (H2D(b)/ASNENMETM) 
for C57BL/6, or RSV tetramer M282 (H-2K(d)/SYGSINNI) were obtained 
from the National Institutes of Health Tetramer Core Facility.
Preparation of cells. Lungs were pressed through wire mesh to obtain a 
  single-cell suspension, which was then enumerated by trypan blue exclusion. 
For DC preparations, lungs were digested for 25 min at 25°C in media con-
taining 1 mg/ml collagenase (Sigma-Aldrich) and 0.02 mg/ml DNase (Sigma-
Aldrich) before single-cell preparation. DCs for reconstitution experiments 
were purified from the lungs of day 6 A/JAPAN/305/57- or A/PR/8/34- 
infected BALB/c or IL-15+/+ and IL-15/ C57BL/6 donors, respectively, 
using MACS technology (Miltenyi Biotec) according to the manufacturer’s 
instructions, or by FACS as previously described (McGill et al., 2008). Purified 
cells were resuspended in Iscove’s DMEM, and 2.5 × 104 cells in 50 µl were 
adoptively transferred i.n. to host mice on day 3 p.i. (McGill et al., 2008).
Purification and adoptive transfer of CL-4 T cells. Single-cell suspen-
sions of splenic cells from CL-4 mice were labeled with CD8 microbeads 
and purified according to the manufacturer’s instructions (Miltenyi Biotec). 
5 × 105 purified CD90.2+ CL-4 cells were then adoptively transferred i.v. 
into BALB/c CD90.1+ congenic mice, or 5 × 105 purified CD90.1+ CL-4 
cells were adoptively transferred i.v. into BALB/c CD90.2+ mice. 24 h later, 
the host mice were infected with influenza as described.
Antibodies  and  reagents. The following reagents were used for these 
studies: rat anti–mouse CD3 (145-2C11), rat anti–mouse CD8 (53-6.7), 
rat anti–mouse IFN- (XMG1.2), rat anti–mouse IA/IE (M5/114.15.2), rat 
anti–mouse  CD11b  (M1/70),  mouse  anti–rat  CD90.1  (OX-7),  hamster 
anti–mouse CD11c (HL3), mouse anti–human Ki67 (B56), and 7-AAD pur-
chased from BD; mouse anti–mouse CD90.2 (5a-8), rat anti–mouse CD45R 
(RA3-6B2), and recombinant human annexin V purchased from Invitrogen; 
and polyclonal goat anti–mouse IL-15R and polyclonal goat anti–mouse 
IL-15 purchased from R&D Systems. i.n. CFSE labeling was performed as 
previously described (Legge and Braciale, 2003; McGill and Legge, 2008, 
2009). BrdU incorporation was assessed using a BrdU Flow kit (BD) accord-
ing to the manufacturer’s instructions, as previously described (McGill and 
Legge, 2008, 2009). FAM caspase 3/7 and caspase 8 kits (Vybrant) were pur-
chased from Invitrogen and used according to the manufacturer’s instruc-
tions. For surface staining, 106 isolated cells were stained with antibody or 
tetramer for 30 min at 4°C and then fixed using FACS Lysing Solution (BD). 
For ICS, fixed cells were permeabilized and labeled with antibodies in FACS 
buffer containing 0.5% saponin (Acros Organics) for 1 h at 4°C. All flow   
cytometry data were acquired on a FACSCalibur or FACSCanto II (both 
from BD) and analyzed using FlowJo software (Tree Star, Inc.).
IL-15 ELISA. The IL-15 ELISA Duo kit was purchased from R&D Sys-
tems. Control and aDC-depleted lungs were harvested on day 6 p.i., ho-
mogenized in 0.5 ml of ELISA diluent (1% BSA in PBS) plus Complete 
Mini EASYpack Protease Inhibitor Cocktail Tablets (Roche), and plated in 
100-µl aliquots. ELISA plates were incubated overnight at 4°C. ELISAs 
were read according to the manufacturer’s instructions.
qRT-PCR analysis for IL-15 mRNA expression. Total RNA was iso-
lated from whole-lung homogenates or from FACS-purified pulmonary DC 
subsets using TRIzol according to the manufacturer’s instructions (Invitro-
gen). cDNA was transcribed from 1 µg RNA using 1 µM 18-mer Oligo dT 
primer and 1 U/µl AMV RT (Promega) in the presence of 1 U/µl RNase 
OUT (Invitrogen), 10 mM dNTP, 25 mM MgCl, and 10× ThermoStart 
PCR reaction buffer (Thermo Fisher Scientific) at 42°C for 60 min in a 
20-µl reaction volume. The qRT-PCR was performed using a sequence 
detector apparatus (ABI Prism 7000; Applied Biosystems) for 40 cycles in a 
two-temperature profile: a denaturation period of 15 s at 94°C followed by a   
1-min annealing/extension period at 60°C. All PCR reactions were performed 
in 25-µl final volumes comprising the following components: 100 ng cDNA, 
TaqMan Universal PCR Master Mix, 450 nM of primers, and 125 nM of 
In summary, we have demonstrated that aDC depletion 
at 48 h p.i. results in increased apoptosis of virus-specific 
CD8 T cells in the lungs and significantly reduced levels of 
pulmonary IL-15 expression after IAV infection. The defect 
in CD8 T cell survival can be rescued by reconstitution of 
pulmonary pDCs and CD8+ DCs via a mechanism that 
requires  direct  DC  trans-presentation  of  IL-15  to  IAV-
  specific CD8 T cells in the lungs. These novel findings sug-
gest a key checkpoint in regulating effector T cell survival 
during pulmonary immune responses, and demonstrate an 
important  and  previously  unrecognized  role  for  DC-
  presented IL-15 in regulating the magnitude of virus-spe-
cific CD8 T cell responses in the lungs, and therein lend 
further support to the recently proposed two-hit model of T 
cell activation (McGill et al., 2008).
MATERIALS AND METHODS
Mice. 6–12-wk-old female BALB/c mice and 6–12-wk-old male and fe-
male C57BL/6 mice were purchased from the National Cancer Institute. 
C57BL/6 IL-15/ (C57BL/6NTac-IL15tm1Imx) mice were purchased from 
Taconic. CL-4 TCR transgenic mice (H-2d; CD90.1+) were purchased 
from  the  Jackson  Laboratory,  and  CL-4  TCR  transgenic  mice  (H-2d; 
CD90.2+) were a gift from L. Sherman (The Scripps Research Institute, La 
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probes. The following primers and probes were used (Overbergh et al., 1999; 
Abebe et al., 2006): IL-15 forward, 5-CATCCATCTCGTGCTACTT-
GTGTT-3; IL-15 reverse, 5-CATCTATCCAGTTGGCCTCTGTTT-3;   
IL-15 probe, FAM-AGGGAGACCTACACTGACACAGCCCAAAA-
BHQ; GAPDH forward, 5-TTCACCACCATGGAGAAGGC-3; GAPDH 
reverse,  5-GGCATGGACTGTGGTCATGA-3;  GAPDH  probe,  FAM-
TGCATCCTGCACCACCAACTGCTTAG-BHQ.
Comparisons were made by the comparative threshold cycle method, 
with GAPDH serving as the comparator. For whole-lung homogenates, 
data are presented as fold change relative to naive lung samples, which are 
set to a value of 1.
IL-15R/Fc treatment. The recombinant mouse IL-15R/Fc chimera was 
purchased from R&D Systems, and control human Fc fragments were   
purchased from the Jackson Laboratory. Mice were anesthetized using   
isofluorane and administered 5 µg IL-15R–Fc or control-Fc i.n. on days 3, 
4, and 5 p.i.
Statistical analysis. Statistical significance of the difference between two 
sets of data was assessed using an unpaired, one-tailed t test or a paired t test 
for control and experimental data groups that could be paired. Differences 
were considered to be statistically significant at P < 0.05.
Online supplemental material. Fig. S1 depicts expression of the tran-
scription factor Ki67 by endogenous polyclonal and transgenic virus-specific 
CD8 T cells in the lungs of control, aDC-depleted, and pulmonary DC–
  reconstituted mice at various time points p.i. Fig. S2 depicts the frequency of 
CL-4 IAV-specific CD8 T cells undergoing apoptosis in the lungs after aDC 
depletion. Fig. S3 shows the effect of blocking pulmonary DC–expressed 
IL-15R on the numbers of CL-4 CD8 T cells in the lungs of aDC- 
depleted mice. Fig. S4 depicts the effects of blocking pulmonary DC– 
expressed IL-15 or IL-15R on virus-specific CD8 T cell apoptosis in the 
lungs of aDC-depleted mice. Fig. S5 shows the frequency and numbers of 
antigen-specific CD8 T cells present in the lungs of wild-type and IL-15/ 
mice after IAV infection. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20091711/DC1.
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